Showing results (551-560 of 583) with videos related to
Sort By:
Pageof 59
Zhongguo Dang Dai Er Ke Za Zhi = Chinese Journal of Contemporary Pediatrics|January 20, 2017
[Clinical characteristics of clonal evolution after immunosuppressive therapy in children with severe/very severe aplastic anemia]Jing-Liao Zhang, Tian-Feng Liu, Li-Xian Chang, et al.Chinese Journal of Cancer|July 2, 2010
Comparative study on anti-tumor immune response of autologous cytokine-induced killer (CIK) cells, dendritic cells-CIK (DC-CIK), and semi-allogeneic DC-CIKQi-Jing Wang, Hui Wang, Ke Pan, et al.Medcomm|July 31, 2025
Applications of Artificial Intelligence in Biotech Drug Discovery and Product DevelopmentYuan-Tao Liu, Le-Le Zhang, Zi-Ying Jiang, et al.Cell Discovery|June 27, 2024
A pan-KRAS degrader for the treatment of KRAS-mutant cancersJie Yang, Qiao-Li Wang, Guan-Nan Wang, et al.Advanced Materials (Deerfield Beach, Fla.)|October 4, 2025
Chimeric Glycoprotein Nanoparticles Elicit Robust Neutralizing Antibodies Against Epstein-Barr VirusCong Sun, Chu Xie, Xin-Yan Fang, et al.Proceedings of the National Academy of Sciences of the United States of America|October 7, 2009
TSLP production by epithelial cells exposed to immunodeficiency virus triggers DC-mediated mucosal infection of CD4+ T cellsDanielle Fontenot, Hong He, Shino Hanabuchi, et al.The Lancet. Oncology|July 11, 2025
Total neoadjuvant treatment with short-course radiotherapy followed by sintilimab plus capecitabine-oxaliplatin versus short-course radiotherapy followed by capecitabine-oxaliplatin in patients with locally advanced rectal cancer (SPRING-01): a single-centre, open-label, phase 2, randomised controlled trialFeng Tian, Honghai Dai, Dan Sha, et al.Nature Communications|March 21, 2018
Peli1 negatively regulates noncanonical NF-κB signaling to restrain systemic lupus erythematosusJunli Liu, Xinfang Huang, Shumeng Hao, et al.Nature Communications|August 12, 2017
Absence of Grail promotes CD8+ T cell anti-tumour activityCara Haymaker, Yi Yang, Junmei Wang, et al.Cancer Cell|September 14, 2010
The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemiaLluis Espinosa, Severine Cathelin, Teresa D'Altri, et al.Pageof 59